Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Cipla
Colorcon
Chinese Patent Office
Baxter
Cantor Fitzgerald
Argus Health
US Department of Justice
Covington

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,255,431

« Back to Dashboard

Summary for Patent: 4,255,431
Title: Gastric acid secretion inhibiting substituted 2-(2-benzimidazolyl)-pyridines, pharmaceutical preparations containing same, and method for inhibiting gastric acid secretion
Abstract:The present invention relates to novel compounds of the formula ##STR1## wherein R.sup.1 and R.sup.2 are the same or different and are each hydrogen, alkyl, halogen, carbomethoxy, carbethoxy, alkoxy, or alkanoyl, R.sup.6 is hydrogen, methyl or ethyl, R.sup.3, R.sup.4 and R.sup.5 are the same or different and are each hydrogen, methyl, methoxy, ethoxy, methoxyethoxy or ethoxyethoxy whereby R.sup.3, R.sup.4 and R.sup.5 are not all hydrogen, and whereby when two of R.sup.3, R.sup.4 and R.sup.5 are hydrogen the third of R.sup.3, R.sup.4 and R.sup.5 is not methyl. The compounds are potent gastric acid secretion inhibitors.
Inventor(s): Junggren; Ulf K. (Molnlycke, SE), Sjostrand; Sven E. (Kungsbacka, SE)
Assignee: Aktiebolaget Hassle (Molndal, SE)
Application Number:06/027,277
Patent Claim Types:
see list of patent claims
Use; Compound; Composition; Formulation; Dosage form;

Drugs Protected by US Patent 4,255,431

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,255,431

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden7804231Apr 14, 1978

International Patents Family Members for US Patent 4,255,431

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 374471 ➤ Subscribe
Austria 374472 ➤ Subscribe
Austria 374473 ➤ Subscribe
Austria 375365 ➤ Subscribe
Austria 389995 ➤ Subscribe
Austria 406119 ➤ Subscribe
Austria A100583 ➤ Subscribe
Austria A100683 ➤ Subscribe
Austria A100783 ➤ Subscribe
Austria A141189 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Mallinckrodt
Queensland Health
Novartis
Merck
AstraZeneca
Chinese Patent Office
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot